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EDEM1’s mannosidase-like domain binds ERAD client
proteins in a redox-sensitive manner and possesses catalytic
activity
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Lydia Lamriben‡§, Michela E. Oster‡, X Taku Tamura‡1, X Weihua Tian¶, Zhang Yang¶, Henrik Clausen¶, and
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Endoplasmic reticulum (ER) degradation-enhancing ␣-mannosidase–like 1 protein (EDEM1) is a protein quality control
factor that was initially proposed to recognize N-linked glycans
on misfolded proteins through its mannosidase-like domain
(MLD). However, recent studies have demonstrated that EDEM1
binds to some misfolded proteins in a glycan-independent manner, suggesting a more complex binding landscape for EDEM1.
In this study, we have identified a thiol-dependent substrate
interaction between EDEM1 and the ␣1-antitrypsin ER-associated protein degradation (ERAD) clients Z and NHK, specifically through the single Cys residue on Z/NHK (Cys256),
required for binding under stringent detergent conditions. In
addition to the thiol-dependent interaction, the presence of
weaker protein-protein interactions was confirmed, suggestive
of bipartite client-binding properties. About four reactive thiols
on EDEM1 were identified and were not directly responsible for
the observed redox-sensitive binding by EDEM1. Moreover, a
protein construct comprising the EDEM1 MLD had thiol-dependent binding properties along with its active glycan-trimming
activities. Lastly, we identified an additional intrinsically disordered region (IDR) located at the C terminus of EDEM1 in addition to its previously identified N-terminal IDR. We also determined that both IDRs are required for binding to the ERAD
component ERdj5 as an interaction with ERdj5 was not observed
with the MLD alone. Together, our findings indicate that
EDEM1 employs different binding modalities to interact with
ERAD clients and ER quality control (ERQC) machinery partners and that some of these properties are shared with its homologues EDEM2 and EDEM3.
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In the ER3 lumen, nascent polypeptides gain access to an
array of molecular chaperones and foldases such as BiP, lectin
molecular chaperones such as calnexin (CNX) and calreticulin
(CRT), and oxidoreductases like PDI and ERp57, all of which
comprise part of the ERQC machinery (1–4). The ERQC
attempts to fold and rescue aberrantly folded proteins by protecting exposed hydrophobic regions (BiP), binding to N-linked
glycans (CNX and CRT), and catalyzing the formation of the
correct disulfide bonds (PDI, ERp57, etc.).
Terminally misfolded proteins are extracted from futile folding cycles, prevented from re-engaging the ERQC machinery,
and ultimately targeted for degradation via the ER-associated
degradation (ERAD) pathway (5, 6). Numerous ERAD components have previously been characterized that recognize
exposed hydrophobic regions, mispaired disulfide bonds, or
specific N-linked glycan structures. For instance, mannosidases
contribute to the extensive glycan trimming that occurs on
ERAD-bound clients, and oxidoreductases are proposed to
facilitate retrotranslocation by unfolding and reducing ERAD
clients to make them translocation-competent (7–9).
The ER degradation-enhancing ␣-mannosidase–like 1 protein (EDEM1) has been proposed to select and sequester terminally misfolded proteins away from productive folding cycles
and target them for degradation. Evidence for these roles
include preferential interaction with misfolded ERAD clients,
direct interaction with ERAD machinery components such as
Sel1L and ERdj5, and acceleration of the degradation of misfolded clients when overexpressed (10 –14).
Although EDEM1 and its role in ERAD have been extensively
studied and characterized since its discovery in 2001 (11, 13),
many of the protein’s properties remain enigmatic. For instance,

3

The abbreviations used are: ER, endoplasmic reticulum; EDEM, ER degradation-enhancing ␣-mannosidase–like protein; MLD, mannosidase-like
domain; ERAD, ER-associated protein degradation; IDR, intrinsically disordered region; ERQC, ER quality control; CNX, calnexin; CRT, calreticulin; PDI,
protein-disulfide isomerase; A1AT, ␣1-antitrypsin; HBS, HEPES-buffered
saline; PEG-maleimide, methoxy polyethylene glycol maleimide; NEM,
N-ethylmaleimide; FL, full length; PNGase F, peptide:N-glycosidase F; Endo
H, endoglycosidase H; NOG, no glycans; DMEM, Dulbecco’s modified
Eagle’s medium; FBS, fetal bovine serum; P/S, penicillin and streptomycin;
HEK, human embryonic kidney; CHO, Chinese hamster ovary; KO, knockout; GS, glutamine synthetase; TX, Triton X-100; CH, CHAPS; BiP, binding
immunoglobulin protein; NHK, null Hong Kong; SSH, Sonic Hedgehog.
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EDEM1 redox-sensitive binding and catalytic activity
Results
The binding of EDEM1 to misfolded A1AT is bipartite and
involves oxidation-dependent and weak protein-protein
interactions
EDEM1 preferentially interacts with misfolded A1AT variants NHK and Z in a glycan-independent manner (10). Given
the oxidative nature of the ER lumen, we determined whether
this preferential interaction is oxidation-dependent. A pulsechase experiment was performed to compare the protein interactions in the absence or presence of the reducing agent dithiothreitol (DTT) (Fig. 1A). EDEM1-FLAG was coexpressed in
human embryonic kidney (HEK) 293T cells with wildtype (WT)
A1AT, Z, or NHK. The proteins were radiolabeled for 30 min
followed by a 15-min chase to allow EDEM1 to reach its mature
folded state. A 30-min chase with or without 5 mM DTT was
performed (⫹/⫺ lanes) following the initial 15-min chase (Fig.
1A). Cells were lysed with 0.5% Triton X-100 (TX) in MNT
buffer (0.5% Triton X-100, 20 mM MES, 100 mM NaCl, 20 mM
Tris-HCl (pH 7.5)) or with 2% CHAPS (CH) in HBS (50 mM
HEPES, 200 mM NaCl (pH 7.5)). Cell lysates were divided into
equal fractions and subjected to anti-A1AT (Fig. 1A, lanes
1–12) and anti-FLAG (Fig. 1A, lanes 13–24) immunoprecipitations. Immunoprecipitations obtained from “TX” lysates were
washed under stringent buffer conditions containing 0.1% SDS,
whereas those obtained from “CH” lysates were washed under
milder conditions using 0.5% CHAPS.
The DTT treatment did not affect the maturation or secretion of WT A1AT as the protein appears to have reached its
mature state as indicated by the presence of complex sugars
acquired in the Golgi as demonstrated by the higher molecular
weight species (Fig. 1A, lanes 1– 4). Additionally, the DTT
treatment did not appear to affect the inherent binding properties of EDEM1 as it did not bind to WT A1AT regardless of
the of the addition of DTT using either TX/SDS or CHAPS
washes (Fig. 1A, lanes 1– 4 and 13–16).
Under mild detergent conditions (CHAPS), the interaction
between EDEM1 and NHK (Fig. 1A, lanes 5, 6, 17, and 18) or Z
(Fig. 1A, lanes 9, 10, 21, and 22) was maintained regardless of
whether DTT was added. However, under stringent detergent
conditions (TX/SDS), the interaction between EDEM1 and
NHK (Fig. 1A, lanes 7, 8, 19, and 20) or Z (Fig. 1A, lanes 11, 12,
23, and 24) was disrupted upon addition of DTT, indicating the
presence of an oxidation requirement as well as the involvement of weaker protein-protein interactions.
WT A1AT and the misfolded variants NHK and Z possess a
single cysteine (Cys) residue at position 256 and three N-linked
glycosylation sites (Fig. 1B). We have previously determined
that the interaction between EDEM1 and NHK is glycanindependent under stringent detergent conditions (10). It was
next determined whether the interaction between A1AT and
EDEM1 involved A1AT Cys256.
C256S mutants of Z and NHK were generated and tested for
their binding to EDEM1 (Fig. 1C). EDEM1-FLAG was coexpressed in HEK293T cells with WT A1AT, Z, Z C256S, NHK, or
NHK C256S. The proteins were radiolabeled for 30 min followed by 1-h chase. Cells were lysed in MNT buffer and washed
in buffer containing 0.1% SDS. EDEM1 no longer interacted
J. Biol. Chem. (2018) 293(36) 13932–13945
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early EDEM1 studies suggested that EDEM1 lacked mannosidase activity, although it shares a mannosidase-like domain
similar to that of the active ER mannosidase Man1b1 (ER ManI)
(11). However, several groups have demonstrated contradictory cellular findings showing that EDEM1 has weak mannosidase activity (15–17). Additionally, attempts to ascertain
on which glycan branch EDEM1 acts have been conducted
by determining the glycan profile of cells in which EDEM1
was overexpressed or knocked out, but in vitro analyses
using recombinant EDEM1 or its MLD are lacking, likely due
to difficulty in expressing recombinant EDEM1 and its MLD
(17, 18).
EDEM1 has been implicated to play a role in ERAD and function in the ER lumen; however, how the protein is retained in
the ER lumen remains undetermined. EDEM1 exhibits dual
topology as a result of inefficient cleavage of its signal peptide, which yields a membrane-bound protein that is able to
act on membrane-associated ERAD clients (19). However,
EDEM1 also exists as a soluble luminal protein that remains
in the ER but lacks a known ER retention/retrieval sequence.
EDEM1 interacts with numerous ER-localized binding partners and is proposed to exist in a multiprotein complex,
which may mediate its ER retention, although this has yet to
be shown.
The client- or machinery-binding properties of EDEM1
appear multifaceted and specific to each binding partner. For
instance, Lederkremer and co-workers (20) showed that N-terminal truncation of EDEM1 possessing a portion of the MLD is
sufficient for binding to H2a. Petrescu and co-workers (21)
identified an N-terminal IDR that is required for interaction
with an unnatural soluble form of tyrosinase, further supporting the nonessential role of the MLD in the interaction between
EDEM1 and H2a or soluble tyrosinase. Likewise, the role of
glycans in EDEM1 client binding is perplexing and appears substrate-specific as in some cases (NHK, H2a, and SHH) interactions with EDEM1 were independent of substrate glycosylation;
however, in other cases glycans appeared required (BACE457)
(10, 12, 20, 22). Interactions between EDEM1 and ER machinery-binding partners have been reported and characterized,
most notably that the EDEM1 MLD was involved in the
interaction with Sel1L as mutating the putative catalytic
triad or using mannosidase inhibitors abolished this interaction (10, 23).
Combined, these results illustrate a much more complex
binding landscape of EDEM1 that involves distinct proteindependent modes of interactions. In this study, we have
identified bimodal interactions between EDEM1 and the
␣1-antitrypsin (A1AT) disease-associated and ERAD variants Z and NHK. The interactions between EDEM1 and
Z/NHK involve covalent and weaker protein-protein interactions that were identified under different detergent conditions. We also provide evidence that the MLD of EDEM1
possesses glycosidase activity. Altogether, these findings
broaden the scope of the EDEM substrate-binding properties and provide further evidence supporting cellular mannosidase activity of the EDEM1 MLD.

EDEM1 redox-sensitive binding and catalytic activity

with Z or NHK when the Cys was mutated to a Ser (Fig. 1C,
lanes 21–24), suggesting that the previously observed covalentlike interaction between the misfolded A1AT ERAD variants
and EDEM1 involved the single Cys256 from A1AT.
EDEM1-FLAG possesses multiple reactive
maleimide-modifiable Cys
To determine whether the interaction between EDEM1 and
NHK or Z involves reactive thiols or unpaired Cys on EDEM1,
we conducted an in-cell maleimide modification assay using
methoxy polyethylene glycol maleimide (PEG-maleimide) (Fig.
2A). HEK293T cells were transfected with EDEM1-FLAG, and

13934 J. Biol. Chem. (2018) 293(36) 13932–13945

a 1-h DTT pretreatment was added to designated dishes. Cells
were lysed in sample buffer containing 5 mM PEG-maleimide
(⫹PEG-maleimide) or 20 mM NEM (⫺PEG-maleimide) to
modify reactive thiols.
Human EDEM1 possesses eight Cys residues that are well
conserved across metazoan species (Fig. S1A). All eight Cys
were modified upon treatment with PEG-maleimide following
DTT pretreatment (Fig. 2A, compare mobility shift between
lanes 3 and 4). However, under oxidizing conditions (⫺DTT
pretreatment), approximately half of the Cys were accessible to
maleimide modification (Fig. 2A, compare lane 2 with lanes 1,
3, and 4) as the modified protein migrates slower than the
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Figure 1. EDEM1 binding to ERAD clients A1AT Z and NHK is bipartite and involves Cys256 on Z/NHK. A, EDEM1-FLAG was coexpressed with A1AT WT,
NHK, or Z in HEK293T cells. Cells were radiolabeled with [35S]Cys/Met for 30 min and chased for 15 min. DTT (5 mM) was added to the cells for 30 min where
indicated (⫹DTT). Cells were lysed in MNT buffer containing TX or CH, and EDEM1 and A1AT were isolated using anti-FLAG (␣-FLAG) and anti-A1AT (␣-A1AT)
antisera. The proteins were resolved by 9% reducing SDS-PAGE. B, cartoon representation of A1AT constructs depicting signal peptide (green), glycosylation
sites (black), and Cys256 (yellow). Arrows denote point mutation E366K on Z and frameshift mutation at 342 on NHK. C, EDEM1-FLAG was coexpressed in
HEK293T cells with A1AT WT, Z, Z C256S, NHK, or NHK C256S. The proteins were radiolabeled with [35S]Cys/Met for 30 min and chased for 1 h. Cells were lysed
in 2% CHAPS or MNT buffer containing 0.1% SDS. Half of the cell lysate was subjected to anti-A1AT immunoprecipitation, and the other half was subjected to
anti-FLAG immunoprecipitation and washed in 0.5% CHAPS or wash buffer containing 0.1% SDS, respectively. Proteins were resolved by 9% reducing
SDS-PAGE. Gels are representative of three independent experiments.

EDEM1 redox-sensitive binding and catalytic activity

unmodified but faster than the fully modified sample, indicating that a subset of the Cys on EDEM1 was accessible and reactive at steady state.
The oxidized and maleimide-modified sample (Fig. 2A, lane
2) was compared with a series of EDEM1 constructs on which a
single Cys-to-Ser mutation was generated to obtain EDEM1
comprising seven, six, five, and four total Cys residues (Fig.
S1B). The number of accessible and reactive Cys on EDEM1
under oxidizing conditions can be estimated as 4 as the protein
migrates at approximately the same level as EDEM1 with four
Cys on SDS-PAGE (Fig. S1B, compare lane 2 with lane 3). Furthermore, modeling of the conserved EDEM1 MLD predicts
that four of the Cys are in sufficient proximity to form two
disulfide bonds (Cys160–Cys529 and Cys410–Cys457) (Fig. 2B, left

panel). The two remaining Cys in the MLD (Cys302 and Cys555)
might act as free thiols. There are two additional Cys found
outside the predicted mannosidase domain, one N-terminal
and the other C-terminal, which could pair up with each other
or with Cys302 or Cys555 or remain free thiols. This information
was used to derive a predicted disulfide map of EDEM1 (Fig. 2B,
right panel).
We next sought to identify the reactive thiols at steady state
using the maleimide modification assay and monitoring the
mobility shifts of each sample under oxidizing conditions compared with that of WT EDEM1 (Fig. 2C). Combinational Cysto-Ser mutants of the predicted reactive Cys (C95S/C302S,
C555S/C629S, C95S/C302S/C629S, and C95S/C302S/C555S/
C629S) were generated and transfected in HEK293T cells. ProJ. Biol. Chem. (2018) 293(36) 13932–13945
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Figure 2. EDEM1 possesses ⬃4 reactive thiols. A, EDEM1-FLAG was expressed in HEK293T cells. Cells were pretreated with DTT (5 mM) where indicated
(⫹/⫺). Cells were lysed in sample buffer containing 5 mM PEG-maleimide (⫹PEG-maleimide) or 20 mM NEM (⫺PEG-maleimide). Proteins were resolved by 8.5%
SDS-PAGE and immunoblotted (IB) with FLAG antibody. B, structural model (Phyre2.0) of the MLD (cyan) showing the three catalytic triad (red) and Cys residues
(yellow). The cartoon representation of EDEM1 depicts signal peptide (green), MLD (cyan), putative catalytic residues (red), Cys residues (yellow), and predicted
disulfides (*). C, FLAG-tagged EDEM1 (WT), C95S/C302S, C555S/C629S, C95S/C302S/C629S, and C95S/C302S/C555S/C629S were expressed in HEK293T cells
and treated as in A. D, FLAG-tagged EDEM1 (WT), C95S/C302S/C629S, and C95S/C302S/C555S/C629S were coexpressed with A1AT WT, Z, and NHK in cells. Cells
were radiolabeled with [35S]Cys/Met for 30 min and chased for 1 h. Cells were lysed in MNT buffer containing 0.1% SDS. Half of the cell lysate was subjected to
anti-A1AT, and half was subjected to anti-FLAG immunoprecipitation. Proteins were resolved by 8.5% reducing SDS-PAGE. The asterisk denotes background
bands. Gels are representative of three independent experiments.

EDEM1 redox-sensitive binding and catalytic activity

Identification of EDEM1 IDRs
Previous studies by Petrescu and co-workers (21) have identified an IDR at the N terminus of EDEM1 that was required for
soluble tyrosinase binding. To address whether other IDRs are
present on EDEM1, the full-length protein sequence was queried using PONDR-FIT, DISOPRED, DisProt, and FoldIndex

13936 J. Biol. Chem. (2018) 293(36) 13932–13945

(24 –27). Each algorithm, with the exception of one, identified
two regions that are predicted as IDRs, located at the N and C
termini of the protein (Fig. S3A, left panel). These IDRs constitute the bulk of the sequence flanking the MLD, making them
potential modes of interaction between EDEM1 and ER quality
control machinery or other possible ERAD clients.
ER localization of the EDEM1 constructs
To investigate the role of the EDEM1 IDRs in localization
and to determine whether a construct comprised solely of the
MLD lacking both IDRs remains ER-localized, we generated
constructs lacking either IDRs (⌬IDR(N) and ⌬IDR(C)) or both
(MLD), which comprises the mannosidase-like domain alone
(Fig. S3A, right panel). Each construct contains the putative
WT EDEM1 signal sequence as well as the same FLAG epitope
at the C terminus. To address whether the truncated constructs
are targeted to the ER, their subcellular localization was monitored by confocal immunofluorescence microscopy (Fig. S3B)
and by endoglycosidase sensitivity (Fig. 3A).
Single transfections of FLAG-tagged EDEM1(FL), ⌬IDR(N),
⌬IDR(C), and MLD were performed in HEK293A cells, and
staining was compared against ER (CRT) or Golgi (Giantin)
markers (Fig. S3B). Signals from each EDEM1 construct colocalized with CRT; however, no colocalization was observed
with the Golgi marker, suggesting that all constructs were ERresident proteins.
EDEM1 and the IDR constructs are predicted to possess multiple N-linked glycosylation consensus sites. EDEM1(FL) was
previously shown to be N-glycosylated; thus, an N-glycosylation assay would reveal whether the EDEM1 constructs lacking
the IDRs were targeted to and reside in the ER (19). The proteins were isolated by immunoprecipitation from cells expressing EDEM1(FL), ⌬IDR(N), ⌬IDR(C), and MLD; deglycosylated
using PNGase F (P) or Endo H (E) or left untreated (U) (Fig. 3A);
and visualized by immunoblotting. PNGase F removes mannose-rich N-glycans found in the ER as well as complex N-glycans that are acquired in the Golgi, whereas Endo H only trims
high-mannose N-glycans encountered in the ER. Because the
molecular mass of an N-linked glycan is ⬃2.5 kDa, glycosylated
proteins should migrate slower on an SDS-polyacrylamide gel
compared with deglycosylated proteins. Mobility shifts upon
PNGase F and Endo H treatment were observed for all EDEM1
IDR constructs (comparing “U” lanes with “P” and “E” lanes),
indicating that ⌬IDR(N), ⌬IDR(C), and MLD were all targeted
to the ER and glycosylated with high-mannose carbohydrates
and did not receive complex N-glycans in the Golgi. Together,
these observations are consistent with ⌬IDR(N), ⌬IDR(C), and
MLD being targeted to and residing in the ER.
EDEM1 MLD preferentially interacts with ERAD substrates
To attempt to reduce EDEM1 down to a smaller functional
unit and to determine whether the conserved N- and C-terminal MLD-flanking regions are required for ERAD client binding, the binding of the EDEM1 constructs to A1AT WT and its
mutant variants was characterized using a radiolabel pulsechase approach (Fig. 3B). The IDRs were not required for the
interaction with Z and NHK as binding to Z and NHK, but not
WT, occurred for both EDEM1 ⌬IDR(N) and ⌬IDR(C) (Fig. 3B,
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teins were subjected to PEG-maleimide modification under
reducing (⫹DTT pretreatment) and nonreducing (⫺DTT pretreatment) conditions. Proteins were resolved by SDS-PAGE
and subjected to immunoblotting.
The resulting blots were positioned such that the reduced
protein samples in each condition were aligned (Fig. 2C, lanes 1,
2, 5, 7, 9, 10, 13, 15, 17, and 19). The mobility shifts of the
oxidized and maleimide-labeled combinational mutants C95S/
C302S and C95S/C302S/C629S were compared with WT
EDEM1 (Fig. 2C, compare lanes 6 and 14 with lane 3), and in
both instances the proteins migrated faster through the gel with
the triple mutant migrating the fastest, indicating that these
constructs possess fewer accessible thiols than the WT protein,
likely two and one, respectively. The same analysis was performed with constructs in which Cys555 was mutated to Ser
(C555S/C629S and C95S/C302S/C555S/C629S); however,
both mutations resulted in a smear when labeled with PEGmaleimide under oxidizing conditions (Fig. 2C, lanes 11 and
18). The same result was obtained with the single C555S point
mutant (data not shown), which may implicate Cys555 in forming transient intermediate disulfides, perhaps as the resolving
Cys residue, which when mutated to a Ser results in mixed
disulfide species.
The interaction between EDEM1 comprising single Cys-toSer mutations and NHK was maintained under stringent detergent conditions (Fig. S2), indicating that a single EDEM1
Cys residue was not solely responsible for maintaining the
interaction. We then determined whether the reactive thiols
contributed to the thiol-dependent interaction that was observed under stringent detergent conditions. To this end, WT
EDEM1-FLAG, C95S/C302S/C629S, and C95S/C302S/C555S/
C629S were coexpressed with A1AT WT, Z, and NHK (Fig.
2D).
The EDEM1-FLAG C95S/C302S/C629S and C95S/C302S/
C555S/C629S constructs both coimmunoprecipitated with Z
and NHK as observed by the presence of EDEM1-FLAG protein
(Fig. 2D, lanes 5, 6, 8, and 9 compared with WT in lanes 1, 4, and
7) with the anti-A1AT immunoprecipitation. These interactions were verified using anti-FLAG immunoprecipitations
where the presence of Z and NHK was observed with the
EDEM1 pulldowns (Fig. 2D, lanes 11, 12, 14, 15, 17, and 18
compared with WT in lanes 10, 13, and 16). Similar to the
WT EDEM1, EDEM1-FLAG C95S/C302S/C629S and C95S/
C302S/C555S/C629S exhibit preferential interaction with
ERAD clients as neither protein interacted with ATAT WT
(Fig. 2D, lanes 10, 13, and 16). Taken together, EDEM1-FLAG
possesses multiple reactive thiols as Cys at positions 95, 302,
555, and 629 appear unpaired and accessible to maleimide
modification at steady state; however, these residues do not
appear to mediate the thiol-dependent interaction that was
observed between EDEM1 and NHK/Z.

EDEM1 redox-sensitive binding and catalytic activity
cific glycan-independent binding property of the MLD. The
MLD also bound to a nonglycosylated NHK, indicating that
binding was glycan-independent (Fig. S3C). Taken together,
these results demonstrate that the EDEM1 MLD possesses the
ability to preferentially interact with the nonnative ERAD clients NHK and Z in a glycan-independent manner.
MLD substrate binding is redox-sensitive

lanes 8, 9, 14, and 15 compared with lanes 7 and 13). The MLD
construct, which lacks both the N- and C-terminal IDRs, also
preferentially binds to misfolded variants Z and NHK over WT
(Fig. 3B, lanes 16 –18).
Moreover, the 3 acidic putative active-site residues were
replaced with positively charged Lys residues (MLD(3K)) to
abolish any potential carbohydrate binding (Fig. 3C, lanes 7–9).
Interestingly, the interaction between MLD(3K) and both NHK
and Z was maintained, whereas no interaction was observed
with WT A1AT, which further validates the ERAD client-spe-

J. Biol. Chem. (2018) 293(36) 13932–13945
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Figure 3. EDEM1 lacking IDRs is targeted to the ER and preferentially
interacts with ERAD substrates. A, HEK293T cells were transfected with
FLAG-tagged EDEM1(FL), ⌬IDR(N), ⌬IDR(C), and MLD. Cells were lysed in MNT
buffer. Lysates and media were subjected to anti-FLAG immunoprecipitation
(IP), and proteins samples were treated with PNGase F (P), Endo H (E), or left
untreated (U). Proteins were resolved by 7.5% reducing SDS-PAGE and immunoblotted against FLAG. The asterisk denotes IgG heavy chain. B, empty plasmid (⫺), EDEM1(FL)-FLAG, ⌬IDR(N)-FLAG, ⌬IDR(C)-FLAG, and MLD-FLAG constructs were cotransfected with the A1AT WT, Z, and NHK in HEK293T cells.
Proteins were radiolabeled for 30 min with [35S]Cys/Met and chased for 1 h.
Lysates were subjected to sequential (first (1), anti-FLAG; second (2), antiA1AT) or single anti-A1AT immunoprecipitation. Proteins were resolved by
reducing 8% SDS-PAGE. C, MLD-FLAG, MLD(3K)-FLAG, and empty plasmid
(Mock) were coexpressed with WT A1AT, Z, or NHK in HEK293T cells. Cells were
radiolabeled with [35S]Cys/Met for 30 min and chased for 1 h. Cells were lysed
in MNT buffer containing Triton X-100. 70% of the lysate was subjected to
sequential immunoprecipitation (first, anti-FLAG; second, anti-A1AT), and
20% was subjected to anti-A1AT immunoprecipitation. The proteins were
resolved by 8% reducing SDS-PAGE. Gels are representative of three independent experiments.

Because the EDEM1 MLD exhibits preferential interaction
with ERAD clients, we next determined whether this interaction involves thiols by monitoring binding upon addition of
DTT (Fig. 4A). A pulse-chase analysis was performed (as
described in Fig. 1A) using a sequential immunoprecipitation
of the protein with anti-FLAG followed by anti-A1AT (Fig. 4A,
lanes 7–12). As expected, the MLD did not interact with WT
A1AT (Fig. 4A, lanes 7 and 8). However, like full-length
EDEM1, the interaction between Z and NHK was oxidationdependent under stringent detergent conditions (Fig. 4A, compare lane 10 with lane 9 and lane 12 with lane 11).
We next determined whether the thiol-dependent interaction involves Cys256 for Z/NHK (Fig. 4B). The MLD was coexpressed in HEK293T cells with A1AT WT, Z, Z C256S, NHK,
NHK C256S, NHK no glycans (NOG), and NHK NOG C256S.
The proteins were radiolabeled for 30 min and chased for 1 h.
The cells were lysed under stringent detergent conditions (TX/
SDS), and protein complexes were isolated by single anti-A1AT
and anti-FLAG immunoprecipitation as well as sequential
immunoprecipitation. The Cys256 residue on NHK/Z also plays
a role in the interaction with the MLD as the Cys-to-Ser mutations abolished the interaction (Fig. 4B, compare lane 6 with
lane 5, lane 15 with lane 14, and lane 17 with lane 16).
The EDEM1 Cys at positions 160, 410, 457, and 529 are predicted to be involved in disulfides (Fig. 2B) and are all found in
the MLD. Additionally, our PEG-maleimide analysis revealed
that these Cys do not appear modified under oxidizing conditions, suggesting that they are either involved in disulfide interactions or not accessible to maleimide modification.
The modeled structure of the MLD predicts two potential
disulfides and two unpaired Cys (Fig. 2B). Our PEG-maleimide
analysis on full-length EDEM1 identified approximately four
reactive thiols and approximately four thiols that are inaccessible to maleimide modification (Fig. 2, A and C). Based on these
results, we expect that a subset (⬃2) of the Cys on the MLD will
be accessible to maleimide modification, whereas the remaining four would not be. Like the full-length EDEM1, a subset of
the Cys residues on MLD is reactive at steady state (Fig. 4C,
compare lane 3 with lanes 1, 2, and 4).
Next, we determined whether the Cys that are predicted to
be paired and experimentally inaccessible to PEG-maleimide
(Cys160, Cys529, Cys410, and Cys457) are involved in the thiol-dependent interaction between MLD and Z/NHK (Fig. 4D). Each
of the Cys/Ser combinational mutants were coexpressed in
HEK293T cells with WT A1AT, Z, and NHK. Radiolabeled proteins were isolated using single immunoprecipitation with antiA1AT antibody (Fig. 4D, lanes 1–3, 10 –12, 19 –21, 28 –30, and
37–39) and anti-FLAG (Fig. 4D, lanes 7–9, 16 –18, 25–27,
34 –36, and 43– 45) and by sequential immunoprecipitation
(Fig. 4D, lanes 4 – 6, 13–15, 22–24, 31–33, and 40 – 42). Binding
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to WT A1AT was not observed regardless of the mutation (Fig.
4D, compare lanes 13, 22, 31, and 40 with lane 4). Binding to Z
and NHK persisted when either predicted disulfide pairs or free
thiols were mutated (Fig. 4D, compare lanes 14, 15, 23, 24, 32,
and 33 with lanes 5 and 6). However, the Cys-less construct did
not exhibit any binding to Z or NHK (Fig. 4D, compare lanes 41
and 42 with lanes 5 and 6), which is likely due to the resulting
compromised structural integrity of the Cys-less MLD.
Altogether, the MLD possesses the ability to bind NHK and Z
in a thiol-dependent manner, involving Cys256 on Z/NHK.
However, the MLD Cys that are predicted to be involved in
disulfides, like the predicted unpaired Cys, are not directly
involved in this interaction. Cys residues appear to function as
structural components of the MLD, and at least one of these
disulfides pairs is required for ERAD client binding.
EDEM1 MLD has glycosidase activity
To further characterize the MLD and elucidate whether it
possesses mannose-trimming properties, the mobility of NHK
on SDS-PAGE was monitored (Fig. 5). A quadruple knockout
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clustered regularly interspaced short palindromic repeats/
CRISPR-associated protein 9 (CRISPR/Cas9) CHO cell line was
used where four mannosidases were knocked out (Man1a1/a2/
b1/c1). The only putative mannosidases that are present in
these knockout cell lines are EDEM1, -2, and -3. Thus, overexpressing the MLD in these cell lines might enhance any trimming effect on NHK as the presence and effect of other functional mannosidases are minimized. NHK was coexpressed in
the quadruple mannosidase knockout CHO cells with a mock
empty plasmid (Fig. 5, lanes 1– 6), the catalytically active
Man1b1-FLAG (Fig. 5, lanes 7–12), EDEM1-FLAG (Fig. 5,
lanes 13–18), EDEM1(3K)-FLAG (Fig. 5, lanes 19 –24), MLDFLAG (Fig. 5, lanes 25–30), MLD(3K)-FLAG (Fig. 5, lanes
31–36), and MLD(Cys-less)-FLAG (Fig. 5, lanes 37– 42) in
addition to NHK with the mannosidase inhibitor kifunensine
(Fig. 5, lanes 43– 45). Proteins were radiolabeled for 30 min and
chased for the indicated times. Consistent with previous data,
mannose trimming was abolished upon addition of kifunensine
(Fig. 5, lanes 43– 45) and mutation of the acidic putative activesite residues on EDEM1 (Fig. 5, compare lanes 22–24 with lanes
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Figure 4. EDEM1 MLD interacts with Z/NHK through Cys256 and possesses reactive thiols. A, MLD-FLAG was coexpressed with A1AT WT, Z, or NHK in
HEK293T cells. Cells were radiolabeled for 30 min and chased for 15 min. DTT (5 mM) was added to the cells for 30 min where indicated (⫹DTT). Cells were lysed
in MNT buffer containing TX. A portion of the lysate (65%) was subjected to sequential immunoprecipitation (first (1), anti-FLAG; second (2), anti-A1AT), 20%
was subjected to anti-A1AT, and 10% was subjected to anti-FLAG. The proteins were resolved by 8% reducing SDS-PAGE. B, MLD-FLAG was coexpressed with
A1AT WT, Z, Z C256S, NHK, NHK C256S, NHK NOG, and NHK NOG C256S in HEK293T cells. Cells were radiolabeled for 30 min, chased for 1 h, and lysed in MNT
buffer. Proteins were immunoprecipitated as in A and resolved by 8% reducing SDS-PAGE. The asterisk denotes a background band. C, MLD-FLAG was
expressed in HEK293T cells. Cells were pretreated for 1 h with DTT (5 mM) where indicated (⫹/⫺). Cells were lysed in sample buffer containing 5 mM
PEG-maleimide (⫹PEG-maleimide) or 20 mM NEM (⫺PEG-maleimide). Proteins were resolved by 8% SDS-PAGE and immunoblotted (IB) against FLAG antibody.
The asterisk denotes a background band. D, MLD-FLAG, MLD C160S/C529S, MLD C410S/C457S, MLD C302S/C555S, and Cys-less MLD were coexpressed in
HEK293T cells with WT A1AT, Z, or NHK. The proteins were radiolabeled for 30 min and chased for 1 h. Proteins were immunoprecipitated as in A and resolved
by 8% reducing SDS-PAGE. Gels are representative of three independent experiments.
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16 –18). Importantly, the MLD also possesses glycan-trimming
ability as observed by the increase in mobility of NHK upon
coexpression with MLD (Fig. 5, lanes 28 –30) compared with
MLD(3K) (Fig. 5, lanes 34 –36). These results indicate that the
MLD is properly folded and possesses glycosidase activity.
Role of IDRs in EDEM1 stability and function
Given that the MLD exhibited similar substrate-binding
properties as that of the full-length EDEM1, we wanted to
determine whether it possessed similar inherent properties of
EDEM1, specifically its short half-life and the ability to associate with another known EDEM1 binding partner, ERdj5.
Half-lives—EDEM1 is reported to have a rapid turnover rate
with a half-life of ⬃2 h (28), especially compared with other
ER-resident proteins such as BiP, a key member of the ER quality control machinery, which is in the range of 28 –33 h (29).
Furthermore, proteins that are intrinsically disordered or contain IDRs possess, on average, a shorter half-life than proteins
lacking any IDRs (30). Specifically, proteins containing long
stretches of disordered regions (⬎30 residues) appear to have
the shortest half-lives. The EDEM1 N- and C-terminal IDR
regions are predicted to be 71 and 69 amino acids in length,
respectively (Fig. S3A, right panel).
We thus postulated that the MLD construct, which lacks
both IDRs, would have the longest half-life. To this end, each
construct bearing a C-terminal FLAG epitope was expressed
in HEK293T cells and subjected to a pulse-chase experiment
after radiolabeling. Following lysis, the proteins were isolated
through immunoprecipitation and resolved by SDS-PAGE (Fig.
6A, left panel). The amount of protein remaining at the indicated time points was quantified and normalized to the starting
amount (Fig. 6A, right panel).
Approximately 50% of EDEM1(FL) remained at the 2-h time
point, whereas only ⬃20% remained at 4 h. These results are
consistent with previous turnover rates of EDEM1 in cell anal-

yses (28). However, the half-life of the MLD construct, which
lacks both IDRs, was ⬃4 h (⬃70% remains at 2 h). Similarly, the
constructs lacking each IDR individually (⌬N/⌬C) have longer
half-lives than the full-length construct. These observations
further validated the identity and presence of two IDRs on
EDEM1 that contribute to the previously observed short halflife of EDEM1.
ERdj5 binding—Because the IDRs were not required for substrate interaction with A1AT misfolded variants (Figs. 3, B and
C, and S3C), we next determined whether the IDRs of EDEM1
were required for binding to the ER oxidoreductase ERdj5.
To this end, FLAG-tagged full-length EDEM1, the EDEM1
IDR deletion constructs, and the MLD were coexpressed with
MYC-tagged ERdj5 in HEK293T cells. The cells were lysed 24 h
post-transfection, and proteins were isolated through coimmunoprecipitation. Binding interactions were monitored through
immunoblotting.
An interaction with ERdj5 was recovered with EDEM1 lacking either one of its IDRs (Fig. 6B, compare lanes 5, 6, 8, and 9
with lanes 2 and 3). However, the interaction with ERjd5 was
lost with EDEM1 lacking both IDRs as displayed by the MLD
(Fig. 6B, compare lanes 11 and 12 with lanes 2 and 3). This
indicated that the presence of either of the IDRs was sufficient
to interact with ERdj5, but the interaction was abolished when
both IDRs were removed with the EDEM1 MLD. Taken
together, these studies with EDEM1 MLD established its ER
localization, determined its substrate binding properties, identified components that support binding to ERdj5, and confirmed it possesses catalytic glycosidase activity in cells.
Conservation of EDEM1 properties in EDEM2 and EDEM3
To determine whether EDEM2 and EDEM3 contain similar
properties to EDEM1, EDEM2 and EDEM3 were characterized
for substrate-binding properties and free thiol content and analyzed for IDRs. Human EDEM2 and EDEM3 were coexpressed
J. Biol. Chem. (2018) 293(36) 13932–13945
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Figure 5. EDEM1 MLD promotes glycan trimming. Top and bottom left panels, empty plasmid (Mock), Man1b1-FLAG, EDEM1-FLAG, EDEM1(3K)-FLAG,
MLD-FLAG, MLD(3K)-FLAG, and MLD(Cys-less)-FLAG were co-expressed with NHK in Man1a1/a2/b1/c1 KO CHO cells. 150 mM kifunensine (KIF) was added for 5 h
prior to the pulse where indicated. Proteins were radiolabeled for 30 min with [35S]Cys/Met and chased for 0, 1, and 2 h. Cells were lysed in MNT buffer, and
lysates were divided equally and subjected to anti-FLAG and anti-A1AT immunoprecipitation. Proteins were resolved by reducing 8% SDS-PAGE. Bottom right
panels, the NHK bands in the designated lanes were magnified, and a red line was drawn through the center of each 0-h time point and through the 4-h time
point to illustrate mobility shifts. Gels are representative of three independent experiments.
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in HEK293T cells with WT A1AT, Z, Z C256S, NHK, NHK
C256S, NHK NOG, and NHK NOG C256S. The proteins were
radiolabeled for 30 min and chased for 1 h. Cells were lysed
under stringent detergent conditions (TX/SDS), lysates were
split into equal portions, and protein complexes were isolated
by anti-FLAG or anti-A1AT immunoprecipitation. Neither
EDEM2 nor EDEM3 associated with WT A1AT (Fig. 7A and B,
lane 6).
Like EDEM1 and the MLD, EDEM2 and EDEM3 coimmunoprecipitated with the ERAD clients Z and NHK (Fig. 7, A and
B, lanes 7 and 9) in a glycan-independent manner (Fig. 7, A and
B, lane 13). However, upon mutating Cys256 to Ser, the interaction was lost (Fig. 7, A and B, compare lane 8 with lane 7, lane 10
with lane 9, and lane 14 with lane 13), suggesting that the thiol
dependence that was observed with EDEM1 and EDEM1 MLD
is a conserved trait among all human EDEM homologues.
Human EDEM2 and EDEM3 possess numerous Cys residues, nine and 11, respectively (Fig. 7, C and D). When subjected to PEG-maleimide modification, both constructs displayed reactive thiols at steady state (Fig. 7, C and D, compare
lane 3 with lanes 1, 2, and 4). Additionally, the EDEM2 and
EDEM3 protein sequences were queried for IDRs, and like
EDEM1, both proteins possess IDRs in regions outside the
MLD, specifically at the C terminus (Fig. 7, C and D).
Together, these results indicate that EDEM1, -2, and -3 possess a conserved redox sensitivity involved in binding to A1AT
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ERAD substrates. The proteins are predicted to contain IDRs;
however, in the case of EDEM1, these regions do not contribute
to Z/NHK binding as the catalytically active EDEM1 MLD
alone is capable of selectively binding to ERAD clients.

Discussion
Protein-to-protein interactions have been observed between
EDEM1 and multiple ERAD clients, including BACE457, cystic
fibrosis transmembrane conductance regulator (CFTR), Rhodopsin, H2a, and A1AT (10 –12, 14, 20, 31). However, the basis
for these substrate-binding interactions is uncertain. Here, we
studied the interaction between EDEM1 and the misfolded
A1AT variants Z and NHK. An additional mode of interaction
that is redox-sensitive was revealed and provided further evidence that the MLD is active and sufficient to selectively bind
the A1AT ERAD clients Z and NHK.
EDEM1 preferentially interacts with Z and NHK but does not
bind to the WT A1AT, suggesting it may recognize elements on
these misfolded proteins that are not present on the properly
folded substrate (10). In the presence of a reducing agent, the
interactions between EDEM1 and Z/NHK were lost under
stringent detergent conditions (Fig. 1A). However, under
milder detergent condition, the interactions persisted (Fig. 1A),
demonstrating the involvement of two types of interactions: a
strong covalent-like, oxidation-dependent interaction as well
as a weak, protein-protein interaction as demonstrated by
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Figure 6. IDRs contribute to EDEM1 half-life but not to the ERjd5 association. A, left panel, FLAG-tagged EDEM1 ⌬IDR(N)/(C), and MLD were transfected into
HEK293T. Proteins were radiolabeled for 30 min with [35S]Cys/Met, and cells were lysed in MNT buffer. Time points were collected at 0, 2, and 4 h after the pulse.
Proteins were resolved by reducing 8% SDS-PAGE. Right panel, the amount of EDEM1 protein remaining at 2 and 4 h was quantified and normalized to the
starting material (0 h) and averaged from three independent experiments. The starting material includes both bands of the observed doublet. Statistical
significance between MLD, EDEM1 ⌬IDR(N), or EDEM1 ⌬IDR(C) and EDEM1(FL) at 4 h was determined by an unpaired t test; the measurement designated ** for
MLD has a p value of 0.005, and that designated * for EDEM1 ⌬IDR(C) is 0.012. Error bars represent mean ⫾ S.E. B, FLAG-tagged EDEM1(FL), EDEM1 ⌬IDR(N),
EDEM1 ⌬IDR(C), and MLD and empty plasmid (Mock) were coexpressed with ERdj5-MYC in HEK293T cells. Cells were lysed in HBS buffer containing CHAPS. 10%
of the lysate was collected for whole-cell lysate (WCL), and 40% was collected for anti-FLAG and anti-MYC immunoprecipitation (IP). Proteins were resolved by
8% reducing SDS-PAGE and immunoblotted against MYC, FLAG, and glucosidase II (GlucII). Gels are representative of three independent experiments.
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the recovered interaction under milder detergent conditions.
The latter protein-protein interactions are possibly mediated
through hydrophobic interactions as such interactions have
been demonstrated between EDEM1 and the ERAD client
BACE457 (32). A model of the EDEM1 MLD structure shows
extensive surface-exposed hydrophobic patches on EDEM1
(Fig. S4), all of which may mediate the observed weak proteinprotein interactions. Identifying the precise hydrophobic patch
(es) involved in this interaction or determining whether other
ERAD clients or machinery interactions involve hydrophobic
interactions with EDEM1 will require further investigation.
The lone cysteine residue located on Z and NHK (Cys256)
contributed to the observed oxidation-dependent interaction
with EDEM1 (Fig. 1, B and C) as the interaction was lost upon
mutating the Cys to Ser under strong detergent conditions but
persisted under mild detergent conditions. This supports the
observed oxidation sensitivity, presumably through a disulfide
bond (Fig. 1C). Interestingly, Cys256 is located in the WT structure in a position that is partially exposed or buried (Fig. S5).
Mutations such as those observed with NHK and Z would
be expected to perturb the structure sufficiently to support
increased accessibility of Cys256 to quality control factors

and ERAD machinery. Additionally, aberrant Cys256-mediated
dimers are formed between Z monomers and NHK monomers,
whereas WT A1AT remains monomeric (33). Mutating the Cys
residue to Ser on Z or reducing disulfides using DTT increased
the secretion of Z as well as increased the complex carbohydrates observed by gel shifts, implicating a role for the Cys in
retention of Z in the ER (33).
The presence of aberrant Cys256-mediated dimers that are
formed between Z monomers and NHK monomers, which do
not occur with WT A1AT, and increased secretion of Z upon
Cys256-to-Ser mutation implicate a role for the Cys in ER retention of aberrantly folded Z, and perhaps NHK, as well as further
provide evidence supporting the increased accessibility of
Cys256 on Z compared with WT A1AT.
This suggests that Cys256 is suitably positioned to act as a
quality control signal when exposed in aberrant structures.
Although a heterodimer between the two proteins (Z and
EDEM1 or NHK and EDEM1) was not readily observable (data
not shown), it is likely that, because EDEM1 is proposed to exist
in the ER as a member of a multiprotein complex, the presence
of monomeric or dimeric Z or NHK would not result in an
observable mobility shift on nonreducing SDS-PAGE.
J. Biol. Chem. (2018) 293(36) 13932–13945
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Figure 7. EDEM2 and EDEM3 exhibit thiol-dependent binding to Z/NHK and expose reactive thiols. A, EDEM2-FLAG was coexpressed with WT A1AT, Z,
Z C256S, NHK, NHK C256S, NHK NOG, and NHK NOG C256S in HEK293T cells. Cells were radiolabeled with [35S]Cys/Met for 30 min and chased for 1 h. Cells were
lysed in MNT buffer containing Triton X-100. EDEM2 and A1AT variants were isolated using anti-FLAG and anti-A1AT immunoprecipitations, respectively.
Proteins were resolved by 9% reducing SDS-PAGE. Asterisks denote background bands. B, same as in A except using EDEM3-FLAG. C, right panel, EDEM2-FLAG
was expressed in HEK293T cells. Cells were pretreated with DTT (5 mM) where indicated (⫹/⫺). Cells were lysed in sample buffer containing 5 mM PEGmaleimide (⫹PEG-maleimide) or 20 mM NEM (⫺PEG-maleimide). Proteins were resolved by 8.5% SDS-PAGE and immunoblotted (IB) with FLAG antibody. Left
panel, cartoon representation of EDEM2 depicting signal peptide (green), MLD (cyan), putative catalytic residues (red), Cys residues (yellow), predicted disulfides
(*), and predicted IDRs (red dashed box). D, left panel, same as in C except using EDEM3-FLAG. Right panel, cartoon representation of EDEM3 depicting signal
peptide (green), MLD (cyan), protease-associated domain (purple), putative catalytic residues (red), Cys residues (yellow), predicted disulfides (*), and predicted
IDRs (red dashed box). Gels are representative of three independent experiments.
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The MLD also exhibited the same oxidation-dependent
binding and sensitivity to Z/NHK Cys256 upon stringent detergent condition, indicating that the ability and selectivity for Z
and NHK binding is inherent to the MLD and did not require
the flanking IDRs (Fig. 4, A and B). However, the covalent interaction is likely mediated through a cofactor as neither of the
predicted disulfides was involved. Although the eight Cys residues on EDEM1 are conserved across species, at least a subset
of them appear to function as structural elements of the MLD as
indicated by loss of ERAD client binding in the absence of all
Cys residues (Fig. 4C).
In addition, the MLD expressed in a cell line deficient for four
mannosidases, Man1a1/a2/b1/c1, exhibited mannose-trimming properties as observed by the mobility shift of NHK on
SDS-PAGE (Fig. 5). The mobility shift was lost upon mutation
of the putative catalytic residues (MLD(3K)), suggesting that
the catalytically inactive MLD(3K) exhibited a dominant negative effect, one in which NHK binds the inactive MLD, thus
preventing it from interacting with the endogenous mannosidases EDEM1/2/3 (Fig. 5) (18). Overexpressing MLD(3K) and
EDEM1(3K) increases their local concentrations to a higher
degree than that of the endogenous EDEM proteins; thus, the
binding of NHK to the exogenous proteins appears to be persistent, possibly not allowing access to the endogenous EDEM
proteins. EDEM1 does not appear to act solely as a mannosidase
as selective interactions with ERAD clients survive prolonged
binding required with the coimmunoprecipitation protocol,
unlike Man1b1 for which an interaction is not recovered. It is
possible that this prolonged interaction indicates a role for
EDEM1 in delivering ERAD clients to the retrotranslocation
machinery. Altogether, these novel findings may facilitate purification of recombinant EDEM1 and its MLD for in vitro biochemical characterization, which has previously been unsuccessful, and potentially help identify the specific glycan branch
on which EDEM1 acts.
In addition to identifying novel redox-sensitive properties
between EDEM1 or the MLD and two ERAD substrates, we
have identified a second IDR located at the C terminus of
EDEM1 (Fig. S3A). Removing either or both IDRs did not affect
the ER targeting or localization of EDEM1 as all constructs
received N-linked glycans and exhibited glycoforms that are
typically found on ER-resident proteins (Fig. 3A). None of the
constructs were recovered in the media fractions, confirming
their cellular retention (Fig. 3A). The ER retention of the MLD
alone appears to require neither a retention sequence like
KDEL nor the N- or C-terminal regions flanking it. Instead,
the ER retention of soluble EDEM1 is a property of the MLD
unlike that of EDEM2, demonstrating a key difference between
the proteins (Fig. 3A and S3B) (39). The construct lacking either
of the IDRs also retained the glycan-independent preferential
interaction with Z and NHK, which is expected as both constructs display intact MLDs (Fig. 3B and S3C).
The present study provides evidence that EDEM1 possesses
two IDRs that contribute to its observed short half-life. Unlike
other ER-resident proteins such as BiP, EDEM1 is rapidly
turned over and exhibits a half-life of ⬃2 h. The stability of
EDEM1 upon removal of both IDRs (EDEM1 MLD) appears to
double the protein half-life from 2 to 4 h, which further sup-
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A putative model of the EDEM1 MLD showed a conserved
barrel structure with the three putative acidic catalytic residues
centered at the core, similar to that of Man1b1 (Fig. 2B) (34).
The model also revealed two potential disulfides as indicated by
their predicted proximities and two unpaired Cys. The predicted map and the presence of reactive thiols were further
tested upon subjection of combinational Cys-to-Ser mutants of
the predicted unpaired Cys residues to PEG-maleimide modification (Fig. 2C). Given the oxidative nature of the ER and the
role of EDEM1 in ERAD, it is surprising that four of the eight
Cys on EDEM1 appear to be accessible to maleimide modification at steady state and suggests that these Cys are likely
involved in a functional aspect of EDEM1, either to form direct
stable or transient bonds with ERAD clients, ERAD machinery,
or other EDEM1 proteins. However, none of the individual Cys
were required to interact with Z or NHK (Fig. S2). Given the
Cys-rich content of EDEM1, it is possible that there is a redundancy in Cys function. The interaction was only abolished when
all Cys were mutated to Ser (Cys-less) in which case the protein
was likely either structurally compromised due to the absence
of disulfide bonds, as one disulfide was sufficient to maintain an
interaction with NHK/Z, or a disulfide is required to act as an
electron acceptor for a free thiol attack by the ERAD substrate.
These results further support the absence of direct involvement
of the Cys of EDEM1 in the apparent redox-sensitive interaction with Z/NHK.
The redox sensitivity of EDEM1 substrate selection likely
involves an oxidoreductase other than ERdj5 because the MLD
exhibits redox-sensitive binding to Z/NHK (Fig. 4, A and B) and
does not interact with ERdj5 (Fig. 6B). It is likely that the interaction between EDEM1 and ERdj5 does not require the MLD as
EDEM1 appears to interact with ERdj5 through its C-terminal
thioredoxin cluster, a region that is not glycosylated (9). Several
groups have demonstrated an interaction between EDEM1
and multiple oxidoreductases, including P5, PDI, ERp57, and
ERp72 (35, 36). Likewise, ERdj3 was recently implicated in the
degradation of the Z variant (37). Additionally, the EDEM3
MLD was recently discovered to form a disulfide bond with the
oxidoreductase ERp46, which promoted the catalytic activity of
EDEM3 (38). Whether these oxidoreductases or others are
involved in the redox-sensitive substrate-binding properties of
EDEM1 remains to be determined.
The truncated MLD construct, in which both regions flanking the EDEM1 MLD were removed, was used to assess the
requirement of paired Cys residues in the EDEM1-Z/NHK
interaction. The fundamental properties of the MLD were
characterized. Although the EDEM2 MLD was expressed and
characterized both in cells and as a recombinant protein, the
properties of the EDEM1 MLD alone are uncharacterized. The
EDEM1 MLD construct is targeted to and retained in the ER in
contrast to the EDEM2 MLD (Figs. 3A and S3B) (39). Importantly, the MLD alone retained the ability to preferentially
interact with ERAD clients in a glycan-independent manner,
indicating that the mannosidase-like domain is sufficient to
interact and preferentially select A1AT ERAD substrates, further reinforcing the MLD requirement in binding to a subset of
ERAD clients (Figs. 3C and S3[[[[[[]C).
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Experimental procedures
Reagents and plasmids
Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine
serum (FBS), and penicillin and streptomycin (P/S) were purchased from Invitrogen. Endo H, PNGase F, and all cloning
reagents were acquired from New England Biolabs. HEK293
cells were purchased from ATCC (lot number 6322631), and
HEK293A cells were purchased from Invitrogen (lot number
1806222). Cells were authenticated by a universal Mycoplasma
detection kit (catalog number 30-1012K, ATCC). [35S]Met/
Cys was acquired from PerkinElmer Life Sciences. Protein
A–Sepharose 4B was from GE Healthcare. The following antibodies were used: ␣-FLAG (catalog number F3165, Sigma),
␣-A1AT (catalog number A0012, Dako), ␣-MYC (catalog number 9B11, Cell Signaling Technology), and ␣-glucosidase II (catalog number PA5-21431, Thermo Fisher). The following C-terminally tagged EDEM1 truncations were generated by PCR
amplification and subcloned into p3XFLAG-CMV-14 (Addgene): EDEM1 ⌬IDR(N) (⌬48 –119), EDEM1 ⌬IDR(C) (⌬583–
652), and EDEM1 MLD (⌬48 –119 and ⌬583– 652). EDEM3MycFLAG was purchased from Origene Technologies (catalog

number RC222885). Transfections were carried out with polyethyleneimine (PEI MAX, catalog number 24765, Polysciences,
Inc.).
Metabolic labeling, affinity purification, and SDS-PAGE
HEK293 or CHO (knockout (KO) man1a1/1a2/1b1/1c1)
cells were grown in 35- or 60-mm dishes where indicated, and
all transfections were carried out for 18 h in DMEM (or minimum Eagle’s medium for CHO cells) supplemented with 10%
FBS and 1% P/S and incubated at 37 °C in 5% CO2. Cells were
lysed on ice with either CHAPS buffer (2% CHAPS in HBS) or
MNT buffer. The postnuclear supernatant was isolated by
centrifugation followed by preclearing with unbound protein
A–Sepharose beads and subsequent incubation with the corresponding antibody and Sepharose beads overnight. Immunopellets were isolated and washed with 0.5% CHAPS in HBS or
Connie’s wash buffer (100 mM Tris-HCl, 300 mM NaCl, 0.1%
SDS, 0.05% Triton X-100 (pH 8.6)) where indicated. Proteins
were eluted from beads with reducing sample buffer followed
by SDS-PAGE. Radiolabeled samples were visualized using
phosphorimaging (FLA-500, Fujifilm) and quantified using
ImageQuant TL 1D gel analysis software (GE Healthcare).
Sequential immunoprecipitation
Immunopellets were washed with 0.5% CHAPS in HBS or
Connie’s wash buffer and eluted from beads with reducing sample buffer. When followed by a second immunoprecipitation,
samples were eluted with 1% SDS in 10 mM Tris (pH 7.5), 150
mM NaCl at 100 °C and quenched with excess 2% CHAPS in
HBS followed by incubation with the corresponding antibody
and Sepharose beads overnight and washing with 0.5% CHAPS
in HBS or Connie’s wash buffer where indicated.
Affinity purification, SDS-PAGE, and immunoblotting
HEK293T cells were grown in 35- or 60-mm dishes, and all
transfections were carried out for 18 h in DMEM supplemented
with 10% FBS and 1% P/S and incubated at 37 °C in 5% CO2.
Cells were lysed on ice with either CHAPS buffer or MNT
buffer. The postnuclear supernatant was isolated by centrifugation followed by preclearing with unbound protein A–
Sepharose beads and subsequent incubation with the corresponding antibody and Sepharose beads overnight. A fraction
of the postnuclear supernatant (10%) was treated with 10%
TCA to collect the whole-cell lysate where indicated. Immunopellets were isolated and washed with 0.5% CHAPS in HBS or
Connie’s wash buffer where indicated. Proteins were either
subjected to glycosidase digestion (following the New England
Biolabs protocol) or eluted from beads with reducing sample
buffer followed by SDS-PAGE. Immunoblots were analyzed via
a LI-COR imaging system (LI-COR Biosciences).
PEG-maleimide modification assay
HEK293T cells were transfected with EDEM1 constructs and
incubated overnight. The next day (⬃20 h later), a subset of the
samples was pretreated with 5 mM DTT for 1 h. Cells were lysed
with sample buffer (30 mM Tris (pH 6.8), 9% SDS, 15% glycerol)
containing 5 mM PEG-maleimide or 20 mM NEM. Lysates were
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ports the regions flanking the EDEM1 MLD as intrinsically disordered (Fig. 6A). Although a 4-h half-life is still considered
short when compared with other ER-resident proteins, the
short half-life of EDEM1 is likely linked to its function in ERAD
to bind misfolded clients as they accumulate in the ER and
target them for degradation. The short half-life is also proposed
as a function of ERAD tuning to return the ER to basal EDEM1
levels once the stress is alleviated (40). The conservation of the
IDRs across EDEM1 in various species further supports their
necessity and role in its function (data not shown).
Although neither the N- nor C-terminal IDRs were required
for binding to Z or NHK, unlike H2a or soluble tyrosinase,
either of the IDRs appears necessary for binding to ERdj5 (Fig.
6B) (20, 21). Like EDEM1, other proteins such as the E3 ligase
San1 and the deubiquitinating enzyme Ubp10 possess IDRs at
both their N and C termini (41, 42). In both cases, the conformational flexibility of the IDRs allows San1 and Ubp10 to bind
multiple partners. EDEM1 may use an analogous mechanism to
bind partners such as ERdj5.
EDEM2 and EDEM3 interact with and accelerate the degradation of Z and NHK (18, 43, 44). This interaction also appears
to be sensitive to the presence of Cys256 on NHK and Z (Fig. 7,
A and B). EDEM2 and EDEM3 also possess reactive thiols at
steady state (Fig. 7, C and D) and interact with the oxidoreductase TXNDC11 (45). Like EDEM1, EDEM2 and EDEM3 are
predicted to possess IDRs (Fig. 7, C and D). These findings
further support conserved properties among the mammalian
EDEM protein family. Together, these findings uncover new
modes of interaction that EDEM1 possesses and broaden the
binding landscape of EDEM1. Specifically, EDEM1 does not
interact with its binding partners or ERAD clients in a “one size
fits all” manner. Instead, EDEM1 binding is multifaceted as different components are utilized depending on the properties or
requirement of the specific binding partner, increasing the versatility of its substrate selectivity.

EDEM1 redox-sensitive binding and catalytic activity
incubated for 1 h. The step-by-step protocol is published in
Braakman et al. (46).
CRISPR/Cas9-targeted KO man1a1/1a2/1b1/1c1 in CHO cells
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